These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32232681)

  • 1. Implantable anti-angiogenic scaffolds for treatment of neovascular ocular pathologies.
    Sarkar B; Siddiqui Z; Kim KK; Nguyen PK; Reyes X; McGill TJ; Kumar VA
    Drug Deliv Transl Res; 2020 Oct; 10(5):1191-1202. PubMed ID: 32232681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
    Andreoli CM; Miller JW
    Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic therapy for ischemic retinopathies.
    Al-Latayfeh M; Silva PS; Sun JK; Aiello LP
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a006411. PubMed ID: 22675660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraocular antiangiogenic drugs in clinical application advantages and disadvantages].
    Li XX
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):870-3. PubMed ID: 23302238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
    Saravia M; Zeman L; Ingolotti M; Schlaen A
    Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular syphilis masquerading as refractory retinal diseases.
    Park SW; Kim KH; Kwon HJ; Byon IS; Khan YH; Nguyen QD
    BMC Infect Dis; 2024 Feb; 24(1):165. PubMed ID: 38326787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
    Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
    Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.
    Dong LF; Yao J; Wang XQ; Shan K; Yang H; Yan B; Jiang Q
    Biochem Biophys Res Commun; 2015 Oct; 465(4):678-84. PubMed ID: 26255966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
    Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept.
    Liu H; Ma Y; Xu HC; Huang LY; Zhai LY; Zhang XR
    Curr Eye Res; 2020 Dec; 45(12):1467-1476. PubMed ID: 32631094
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Era in Reducing Treatment Burden in Retinal Disease.
    Retina; 2021 Apr; 41(Suppl 1):S1-S12. PubMed ID: 33787534
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti-Vascular Endothelial Growth Factor Therapy.
    Farinha C; Santos T; Santos AR; Lopes M; Alves D; Silva R; Cunha-Vaz J
    Retina; 2020 May; 40(5):881-890. PubMed ID: 30689620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
    Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.